Reference
Kong D, et al. Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center. Frontiers in Immunology 14: 24 May 2023. Available from: URL: https://www.frontiersin.org/journals/immunology#
Rights and permissions
About this article
Cite this article
Antineoplastics/entecavir. Reactions Weekly 1973, 47 (2023). https://doi.org/10.1007/s40278-023-45775-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-45775-z